Antibiotic control of tumor-colonizing salmonella enterica serovar typhimurium

Experimental Biology and Medicine

Volumn 236, Issue 11, 2011, Pages 1282-1290

  Crull, Katja ^a   Weiss, Siegfried ^a  

^a HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

Antibiotics; Ciprofloxacin; Salmonella typhimurium; Solid tumor; Tumor targeting

Indexed keywords

CIPROFLOXACIN; KANAMYCIN; TETRACYCLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC THERAPY; ANTINEOPLASTIC ACTIVITY; ARTICLE; BACTERIA MEDIATED TUMOR THERAPY; BACTERIAL COLONIZATION; BACTERIAL STRAIN; CANCER THERAPY; COLON CARCINOMA; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; FEMALE; INFECTION CONTROL; MOUSE; NONHUMAN; SALMONELLA TYPHIMURIUM; SALMONELLA TYPHIMURIUM SL7207; THERAPY EFFECT; TREATMENT OUTCOME;

ANIMALS; ANTI-INFECTIVE AGENTS; CARCINOMA; CIPROFLOXACIN; COLONIC NEOPLASMS; DISEASE MODELS, ANIMAL; FEMALE; MICE; MICE, INBRED BALB C; SALMONELLA INFECTIONS; SALMONELLA TYPHIMURIUM;

BACTERIA (MICROORGANISMS); MUS; SALMONELLA; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHIMURIUM; SALMONELLA TYPHIMURIUM;

EID: 80055111822     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1258/ebm.2011.011111     Document Type: Article

References (31)

1. Hoption Cann SA, van Netten JP, van Netten C. Dr William Coley and tumour regression: a place in history or in the future. Postgrad Med J 2003;79:672-680
2. Ebbell B. The Papyrus Ebers: The Greatest Egyptian Medical Document. London: Oxford Press, 1937
3. Coley WB. The treatment of malignant tumors by repeated inoculations of erysipelas. With a report of ten original cases. Clin Orthop Relat Res 1893;10:3-11
4. Leschner S, Weiss S. Salmonella-allies in the fight against cancer. J Mol Med 2010;88:763-773
5. Wei MQ, Mengesha A, Good D, Anne J. Bacterial targeted tumour therapy - dawn of a new era. Cancer Lett 2008;259:16-27
6. Low KB, Ittensohn M, Luo X, Zheng LM, King I, Pawelek JM, Bermudes D. Construction of VNP20009: a novel, genetically stable antibiotic-sensitive strain of tumor-targeting Salmonella for parenteral administration in humans. Methods Mol Med 2004;90:47-60
7. Crull K, Bumann D, Weiss S. Influence of infection route and virulence factors on colonization of solid tumors by Salmonella enterica serovar Typhimurium. FEMS Immunol Med Microbiol 2011;62:75-83
8. Graham FO, Coleman PN. Infection of a secondary carcinoma by Salmonella montevideo. Br Med J 1952;1:1116
9. Brown JM, Giaccia AJ. The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. Cancer Res 1998;58:1408-1416
10. Harris AL. Hypoxia - a key regulatory factor in tumour growth. Nat Rev Cancer 2002;2:38-47
11. Leschner S, Westphal K, Dietrich N, Viegas N, Jablonska J, Lyszkiewicz M, Lienenklaus S, Falk W, Gekara N, Loessner H, Weiss S. Tumor invasion of Salmonella enterica serovar Typhimurium is accompanied by strong hemorrhage promoted by TNF-alpha. PLoS One 2009;4:e6692
12. Petrache I, Verin AD, Crow MT, Birukova A, Liu F, Garcia JG. Differential effect of MLC kinase in TNF-alpha-induced endothelial cell apoptosis and barrier dysfunction. Am J Physiol Lung Cell Mol Physiol 2001;280:L1168-L1178
13. Westphal K, Leschner S, Jablonska J, Loessner H, Weiss S. Containment of tumor-colonizing bacteria by host neutrophils. Cancer Res 2008;68:2952-2960
14. Avogadri F, Martinoli C, Petrovska L, Chiodoni C, Transidico P, Bronte V, Longhi R, Colombo MP, Dougan G, Rescigno M. Cancer immunotherapy based on killing of Salmonella-infected tumor cells. Cancer Res 2005;65:3920-3927
15. Pawelek JM, Low KB, Bermudes D. Tumor-targeted Salmonella as a novel anticancer vector. Cancer Res 1997;57:4537-4544
16. Rietschel ET, Kirikae T, Schade FU, Mamat U, Schmidt G, Loppnow H, Ulmer AJ, Zahringer U, Seydel U, Di Padova F. Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J 1994;8:217-225
17. Gunn JS. The Salmonella PmrAB regulon: lipopolysaccharide modifications, antimicrobial peptide resistance and more. Trends Microbiol 2008;16:284-290
18. Hornef MW, Wick MJ, Rhen M, Normark S. Bacterial strategies for overcoming host innate and adaptive immune responses. Nat Immunol 2002;3:1033-1040
19. Guo L, Lim KB, Gunn JS, Bainbridge B, Darveau RP, Hackett M, Miller SI. Regulation of lipid A modifications by Salmonella typhimurium virulence genes phoP-phoQ. Science 1997;276:250-253
20. Bauss F, Droge W, Mannel DN. Tumor necrosis factor mediates endotoxic effects in mice. Infect Immun 1987;55:1622-1625
21. Hoiseth SK, Stocker BA. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature 1981;291: 238-239
22. Zhao M, Yang M, Li XM, Jiang P, Baranov E, Li S, Xu M, Penman S, Hoffman RM. Tumor-targeting bacterial therapy with amino acid auxotrophs of GFP-expressing Salmonella typhimurium. Proc Natl Acad Sci USA 2005;102:755-760
23. Arrach N, Cheng P, Zhao M, Santiviago CA, Hoffman RM, McClelland M. High-throughput screening for Salmonella avirulent mutants that retain targeting of solid tumors. Cancer Res 2010;70:2165-2170
24. Low KB, Ittensohn M, Le T, Platt J, Sodi S, Amoss M, Ash O, Carmichael E, Chakraborty A, Fischer J, Lin SL, Luo X, Miller SI, Zheng L, King I, Pawelek JM, Bermudes D. Lipid A mutant Salmonella with suppressed virulence and TNFalpha induction retain tumor-targeting in vivo. Nat Biotechnol 1999;17:37-41
25. Loessner H, Endmann A, Leschner S, Westphal K, Rohde M, Miloud T, Hammerling G, Neuhaus K, Weiss S. Remote control of tumour-targeted Salmonella enterica serovar Typhimurium by the use of L-arabinose as inducer of bacterial gene expression in vivo. Cell Microbiol 2007;9:1529-1537
26. Denton M. Enterobacteriaceae. Int J Antimicrob Agents 2007;29(Suppl. 3):S9-S22
27. Asperilla MO, Smego RA Jr, Scott LK. Quinolone antibiotics in the treatment of Salmonella infections. Rev Infect Dis 1990;12:873-889
28. Furuya EY, Lowy FD. Antimicrobial-resistant bacteria in the community setting. Nat Rev Microbiol 2006;4:36-45
29. Toso JF, Gill VJ, Hwu P, Marincola FM, Restifo NP, Schwartzentruber DJ, Sherry RM, Topalian SL, Yang JC, Stock F, Freezer LJ, Morton KE, Seipp C, Haworth L, Mavroukakis S, White D, MacDonald S, Mao J, Sznol M, Rosenberg SA. Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma. J Clin Oncol 2002;20:142-152
30. Zhao M, Yang M, Ma H, Li X, Tan X, Li S, Yang Z, Hoffman RM. Targeted therapy with a Salmonella typhimurium leucine-arginine auxotroph cures orthotopic human breast tumors in nude mice. Cancer Res 2006;66:7647-7652
31. Westphal K, Leschner S, Jablonska J, Loessner H, Weiss S. Containment of tumor-colonising bacteria by host neutrophils. Cancer Res 2008;68:2952-2960